Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo.

@article{Zhu2006MesenchymalSC,
  title={Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo.},
  author={Wei Zhu and Wenrong Xu and Runqiu Jiang and Hui Qian and Miao Chen and Jiabo Hu and Weike Cao and Chongxu Han and Yong-chang Chen},
  journal={Experimental and molecular pathology},
  year={2006},
  volume={80 3},
  pages={267-74}
}
Mesenchymal stem cells (MSCs) have generated a great deal of interest in clinical application because of their potential use in regenerative medicine and tissue engineering. However, the therapeutic application of MSCs still remain limited unless the favorable effect of MSCs for tumor growth in vivo and the long-term safety of the clinical applications of MSCs are better understood. In this study, MSCs derived from fetal bone marrow (FMSCs) and adult MSCs (AMSCs) alone or FMSCs and AMSCs with… CONTINUE READING